drugset / Trial / NCT00251966

ASTERIX: Low Dose ASA and Nexium

NCT00251966

Phase 3 Completed 960 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of the study is to evaluate the effect of esomeprazole 20 mg od versus placebo for the prevention of gastric and/or duodenal ulcers in patients taking low-dose ASA.

Timeline

Start
2004-05
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 20 mg